PT  - JOURNAL ARTICLE
ED - BMJ Publishing Group Ltd
TI  - Correction: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
AID  - 10.1136/jitc-2022-006348corr1
DP  - 2023 Jul 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e006348corr1
VI  - 11
IP  - 7
4099  - http://jitc.bmj.com/content/11/7/e006348corr1.short
4100  - http://jitc.bmj.com/content/11/7/e006348corr1.full
SO  - J Immunother Cancer2023 Jul 01; 11